PetCaseFinder

Peer-reviewed veterinary case report

Serum cobalamin and folate as prognostic factors in canine exocrine pancreatic insufficiency: An observational cohort study of 299 dogs.

Journal:
Veterinary journal (London, England : 1997)
Year:
2019
Authors:
Soetart, N et al.
Affiliation:
Department of Biology · France
Species:
dog

Plain-English summary

Exocrine pancreatic insufficiency (EPI) is a condition in dogs that makes it hard for them to absorb nutrients properly, often leading to issues with vitamins like cobalamin (a type of vitamin B12) and folate. In a study of 299 dogs with EPI, researchers found that many had low cobalamin levels and high folate levels, which can affect their health outcomes. Dogs who had low cobalamin when diagnosed tended to be older and had a lower chance of survival, especially if they were not receiving enzyme replacement therapy and had a decreased appetite. Interestingly, having high folate levels seemed to be linked to a better prognosis. Overall, the study highlights the importance of checking vitamin levels when diagnosing EPI, as low cobalamin can indicate a poorer outlook for the dog.

Abstract

Exocrine pancreatic insufficiency (EPI) in dogs is a gastrointestinal condition leading to a severe impairment of nutrient absorption. The disease is frequently associated with vitamin disturbances especially regarding cobalamin and folate. Dogs with EPI need daily expensive supportive treatment. The aim of the present study was to identify prognostic factors for EPI in dogs, through a long-term survival study of 299 dogs, taking into account epidemiological, clinical, biological and therapeutic data, with particular emphasis on serum cobalamin and folate concentration. The prevalence of low serum cobalamin (cobalamin<350ng/L) and high serum folate (folate>12&#x3bc;g/L) concentrations were 67% (200/299) and 55% (164/299), respectively. Dogs with hypocobalaminemia at diagnosis were significantly older than those with serum cobalamin concentration within the reference interval (P<0.001). Hypocobalaminemia at diagnosis (P=0.04), male sex (P=0.01), decreased appetite at diagnosis (P=0.008) and not receiving enzyme replacement therapy (P=0.003) were significant and independent risk factors for decreased survival in EPI. In contrast, hyperfolatemia was associated with improved prognosis (P=0.02). These results confirm the importance of measuring serum cobalamin and folate concentrations at the time EPI is diagnosed, as hypocobalaminemia is negatively associated with prognosis, particularly in the absence of a high serum folate concentration.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/30606434/